Heterobicyclic inhibitors of MAT2A and methods of use for treating cancer Grant US-11524960-B2 United States of America 13 Dec 2022
Therapy of tumors and infectious agents deficient in methylthioadenosine phosphorylase Application US-8796241-B2 United States of America 05 Aug 2014